$0.76
1.12% day before yesterday
Nasdaq, Nov 14, 10:00 pm CET
ISIN
IL0011814113
Symbol
PLRZ

Polyrizon Stock price

$0.76
-0.41 34.89% 1M
-2.39 75.82% 6M
-541.74 99.86% YTD
-204.24 99.63% 1Y
-386.74 99.80% 3Y
-386.74 99.80% 5Y
-386.74 99.80% 10Y
-386.74 99.80% 20Y
Nasdaq, Closing price Fri, Nov 14 2025
-0.01 1.12%
ISIN
IL0011814113
Symbol
PLRZ
Industry

Key metrics

Basic
Market capitalization
$4.6m
Enterprise Value
$-11.3m
Net debt
positive
Cash
$15.8m
Shares outstanding
5.9m
Valuation (TTM | estimate)
P/E
negative | -
P/S
- | -
EV/Sales
- | -
EV/FCF
4.3
P/B
0.3
Financial Health
Equity Ratio
95.3%
Return on Equity
-30.4%
ROCE
-20.6%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | -
EBITDA
$-3.5m | -
EBIT
$-3.8m | -
Net Income
$-1.8m | -
Free Cash Flow
$-2.6m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
- | -
EBIT
- | -
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-1.2
FCF per Share
$-0.4
Short interest
2.3%
Employees
-
Rev per Employee
-
Show more

Is Polyrizon a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Financial data from Polyrizon

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 2.48 2.48
-
-
- Research and Development Expense 1.31 1.31
-
-
-3.48 -3.48
-
-
- Depreciation and Amortization 0.31 0.31
-
-
EBIT (Operating Income) EBIT -3.79 -3.79
-
-
Net Profit -1.78 -1.78
-
-

In millions USD.

Don't miss a Thing! We will send you all news about Polyrizon directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Polyrizon Stock News

Neutral
GlobeNewsWire
10 days ago
In-Vitro Data Confirms Strong Protection Against H1N1 Influenza via Physical Barrier Mechanism Ra'anana, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company developing intranasal products based on its proprietary Capture & Contain (C&C) platform, today announced positive in-vitro results for its product candidate, the P...
Neutral
GlobeNewsWire
about one month ago
Ra'anana, Israel, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company developing intranasal products based on its proprietary Capture & Contain (C&C) platform, today announced encouraging results from a recent pre-clinical study evaluating the allergen-blocking performance of its PL-14 Allergy Blocker formulation. The study was...
Neutral
GlobeNewsWire
about 2 months ago
Ra'anana, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced the submission of its full pre-submission (Pre-Sub) package to the U.S. Food and Drug Administration (FDA) for its PL-14 product, designed to help individuals suffering from nasal allergies....
More Polyrizon News

Company Profile

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Head office Israel
CEO Tomer Izraeli
Founded 2005
Website polyrizon-biotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today